Toulmonde, Maud
Guegan, Jean-Philippe
Spalato-Ceruso, Mariella
Peyraud, Florent
Kind, Michèle
Vanhersecke, Lucile
Le Loarer, François
Perret, Raul
Cantarel, Coralie
Bellera, Carine
Bessede, Alban
Italiano, Antoine
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR 21 RHUS 0010, ANR 21 RHUS 0010, ANR 21 RHUS 0010, ANR 21 RHUS 0010)
Article History
Received: 15 January 2024
Accepted: 25 January 2024
First Online: 20 February 2024
Declarations
:
: research grant (ASTRAZENECA, BAYER, BMS, IPSEN, MERCK, MSD, NOVARTIS, PARTHENON, ROCHE); advisory board (ASTRAZENECA, BAYER, BMS, DAIICHI SANKYO, IPSEN, MERCK, MSD, NOVARTIS, PARTHENON, ROCHE).
: employees of Explicyte. The other authors have nothing to declare.
: This study was approved by the Comité de Protection des Personnes (CPP) Sud-Ouest et Outre Mer III (Bordeaux, France) according to good clinical practices and applicable laws and regulations. All methods were performed in accordance with the relevant guidelines and regulations. All patients provided written informed consent.
: The article does not contain any individual person’s data.
: AI: research grant (ASTRAZENECA, BAYER, BMS, IPSEN, MERCK, MSD, NOVARTIS, PARTHENON, ROCHE); advisory board (ASTRAZENECA, BAYER, BMS, DAIICHI SANKYO, IPSEN, MERCK, MSD, NOVARTIS, PARTHENON, ROCHE)JPG, AB: employees of ExplicyteThe other authors have nothing to declare.